Authors of a new study into the human papillomavirus vaccine have claimed that the vaccine is not linked to 44 serious chronic diseases.
The study, published in the Journal of Medicine, has been hailed as ‘the most comprehensive study of HPV vaccination in adult women to date’.
As part of the research, a team from a Danish cancer society analysed data from more than three million women in Denmark and Sweden who had received the HPV vaccine.
The study included mostly adolescent women, but the cohort was also made up of women who received a ‘catch-up’ vaccine later in life.
At the end of the research, the team were able to establish that the vaccine was not linked to 44 serious chronic diseases.
The team did, however, notice that the study’s Danish cohort stood an increased risk of developing coeliac disease. They stated that there were no other serious safety concerns observed in the study.
Key researcher Anders Hviid set the scene, writing: “This is the most comprehensive study of HPV vaccination in adult women to date.
“It is not unreasonable to expect different safety concerns in adult women compared with young girls, and our study is an important supplement to the safety studies in young girls.”
The research comes after Minister for Health Simon Harris spoke out to criticise anti-HPV vaccine campaigners.
“Unfounded, false claims have been made of an association between HPV vaccination and a number of conditions experienced by a group of young women,” he said, at an event earlier this year.
“There is no scientific evidence that the HPV vaccine causes any long-term illnesses.”
Minister Harris went on to ask ‘scaremongers’ to ‘butt out’.
In the Republic of Ireland, the HPV vaccine is offered to girls in their first year of secondary school. A number of people have advocated against the vaccine, however, linking it to sudden and unexplained illness in their own children.
Experts have always maintained that there is no link between these cases and the vaccine. No doubt they will take confidence from the latest research findings.